Pharmaceutical - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

26 to 50 of 7222 results

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

Ferring acquires novel drug delivery technology from CTCBIO

24-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has signed an agreement with CTCBIO…

CTCBIOFerring PharmaceuticalsLicensingPharmaceutical

Aquavit to invest in biopharma R&D and manufacturing in South Korea

24-02-2015

Aquavit Life Sciences, the South Korea-based subsidiary of privately-held US firm Aquavit Pharmaceuticals,…

AquavitPharmaceuticalProductionResearchSouth Korea

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

24-02-2015

The Medicines Patent Pool has announced a license with US pharma giant Merck & Co for pediatric formulations…

Anti-viralsMerck & CoPharmaceuticalProductionRaltegravir Tablets

US FDA approves Novartis’ Farydak, the first HDAC inhibitor for MM patients

24-02-2015

The US Food and Drug Administration yesterday approved Swiss pharma giant Novartis’ Farydak (panobinostat,…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

Eli Lilly delays US and Europe filings for new diabetes agent peglispro

23-02-2015

US pharma major Eli Lilly says it is delaying the submission of its basal insulin peglispro (BIL) to…

DiabetesEli LillyEuropepeglisproPharmaceuticalRegulationUSA

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

23-02-2015

US pharma major Bristol-Myers Squibb has signed a definitive agreement to acquire all of the outstanding…

Bristol-Myers SquibbF001287FlexusLicensingMergers & AcquisitionsOncologyPharmaceuticalRigel Pharmaceuticals

Advagraf plus basiliximab results in significantly better renal function

23-02-2015

Data published last week in the American Journal of Transplantation demonstrate that in liver transplant…

AdvagrafAstellas PharmaBasiliximabNephrology and HepatologyPharmaceuticalResearch

Valeant fourth-qtr 2014 earnings beat expectations

Valeant fourth-qtr 2014 earnings beat expectations

23-02-2015

Canada’s Valeant Pharmaceutical International posted financial results late Sunday, showing that fourth-quarter…

FinancialPharmaceuticalValeantValeant Pharmaceutical InternationalValeant Pharmaceuticals International

Almirall reports strong 2014 financial results following AstraZeneca transfer

Almirall reports strong 2014 financial results following AstraZeneca transfer

23-02-2015

Almirall, Spain’s largest drugmaker, has continued its upward trend and reported strong results for…

AlmirallEkliraFinancialPharmaceuticalSativexSpain

Dupilumab Phase IIb shows improvement in patient-reported outcomes for dermatitis

Dupilumab Phase IIb shows improvement in patient-reported outcomes for dermatitis

23-02-2015

A Phase IIb study of dupilumab, from Sanofi and Regeneron, has shown that the drug improved patient-reported…

DermatologicalsdupilumabPharmaceuticalRegeneronResearchSanofi

Report: Cutting pharmacies in Russia could benefit patients

23-02-2015

A reduction in the number of pharmacies in Russia could lead to cheaper drug prices for patients, according…

KazakhstanMarkets & MarketingMedicinal chemistryPharmaceuticalPharmacistRussiaUkraine

Access to medicines: evolving the European debate

Access to medicines: evolving the European debate

23-02-2015

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the debate…

EuropeHealthcarePharmaceuticalPoliticsPricing

UPDATE: Valeant confirms $10 billion offer for Salix

UPDATE: Valeant confirms $10 billion offer for Salix

23-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International late Sunday confirmed it has reached…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Valeant in final stages of making $10 billion offer for Salix; reports

Valeant in final stages of making $10 billion offer for Salix; reports

22-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International could announce an around $10 billion…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Takeda links with a London university to develop novel gastroenterology products

Takeda links with a London university to develop novel gastroenterology products

22-02-2015

The UK’s Queen Mary University of London (QMUL) and Takeda Pharmaceutical, Japan’s largest drugmaker,…

Gastro-intestinalsPharmaceuticalResearchTakeda PharmaceuticalUKUniversity of London

Novo Nordisk shares jump on positive trial results with OG217SC

Novo Nordisk shares jump on positive trial results with OG217SC

20-02-2015

Shares of Danish diabetes care giant Novo Nordisk jumped 5% to 312.20 Danish kroner in early afternoon…

DenmarkDiabetesNovo NordiskOG217SCPharmaceuticalResearchsemaglutide

Cloud computing offers big data solutions to big pharma

Cloud computing offers big data solutions to big pharma

20-02-2015

Pharmaceutical companies spend upwards of a decade and a billion dollars to bring new drugs and therapies…

AstraZenecaCode-NExostarPharmaceuticalResearch

Astellas announces reorganization of its North American operation and business development

Astellas announces reorganization of its North American operation and business development

20-02-2015

Japanese drug major Astellas Pharma is to make organizational and personnel changes in the Americas,…

AstellasAstellas Pharma Canada IncBoardroomPharmaceuticalUSA

Ferring launches Cortiment in Europe and publishes new efficacy data

Ferring launches Cortiment in Europe and publishes new efficacy data

20-02-2015

Switzerland-headquartered privately-held pharma company Ferring has announced the European launch Cortiment…

CortimentEuropeFerringGastro-intestinalsMarkets & MarketingPharmaceuticalResearch

FDA accepts and grants priority review for Genentech's cobimetinib/Zelboraf

FDA accepts and grants priority review for Genentech's cobimetinib/Zelboraf

20-02-2015

Genentech, part of the Roche Group, says that the US Food and Drug Administration has accepted and granted…

cobimetinibGenentechOncologyPharmaceuticalRegulationRocheUSA

Lilly accepts committee recommendation to extend evacetrapib study by six months

Lilly accepts committee recommendation to extend evacetrapib study by six months

20-02-2015

US drug major Eli Lilly has accepted the recommendation of the ACCELERATE study academic executive committee…

Cardio-vascularEli LillyevacetrapibPharmaceuticalResearchUSA

EU health stakeholders set up EMVO to help fight counterfeit medicines

EU health stakeholders set up EMVO to help fight counterfeit medicines

20-02-2015

Major European health care stakeholders have taken a major step to secure the legitimate pharmaceutical…

EuropeHealthcarePharmaceuticalRegulation

Merck Serono and Sysmex Inostics open first liquid biopsy RAS biomarker testing center

Merck Serono and Sysmex Inostics open first liquid biopsy RAS biomarker testing center

20-02-2015

Merck Serono, the biopharmaceutical business of Germany’s Merck KGaA, announced today that the first…

Merck KGaAMerck SeronoOncologyPharmaceuticalResearchSpainSysmex Inostics

26 to 50 of 7222 results

COMPANY SPOTLIGHT

Menarini

Back to top